Resource Repository | Regulatory Resources

Filter by Category:

Informed Consent for Clinical Trials

Audience: Industry,Regulatory Resource,Website

Informed Consent for Clinical Trials Informed Consent for Clinical Trials | FDA Informational page ...

Institutional Review Board Written Procedures: Guidance for Institutions and IRBs

Audience: Industry & PAG,Guidance,Regulatory Resource

Institutional Review Board Written Procedures: Guidance for Institutions and IRBs Institutional ...

FDA Guidance on Engaging Community and Advocates in Diversity

Audience: Industry,Collaboration Guidance Documents,Guidance,Increasing diversity and inclusion in recruitment,Regulatory Resource

FDA Guidance on Engaging Community and Advocates in Diversity Guidance on Engaging Community and ...

International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use

Audience: Industry,Collaboration Guidance Documents,Designing a patient-centric protocol,Guidance,Regulatory Resource

International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use ...

Regulations: Good Clinical Practice and Clinical Trials

Audience: Industry,Collaboration Guidance Documents,Designing a patient-centric protocol,Guidance,Regulatory Resource

Regulations: Good Clinical Practice and Clinical Trials Regulations: Good Clinical Practice and ...

Enhancing Benefit-Risk Assessment in Regulatory Decision-Making

Audience: Industry,Demonstrating Value to Stakeholders,Designing a patient-centric protocol,Guidance,Regulatory Resource,Training Modules

Enhancing Benefit-Risk Assessment in Regulator Decision-Making Enhancing Benefit-Risk Assessment in ...

Assessment of the Use of Patient Experience Data in Regulatory Decision-Making

Audience: Industry,Guidance,Increasing diversity and inclusion in recruitment,Regulatory Resource,Training Modules,Utilizing Patient Experience and Registry Data

Assessment of the Use of Patient Experience Data in Regulatory Decision-Making Assessment of the Use ...

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Audience: Industry,Diversity & Engagement Modules,Guidance,Increasing diversity and inclusion in recruitment,Regulatory Resource

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, ...

Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data

Audience: Industry,Diversity & Engagement Modules,Guidance,Increasing diversity and inclusion in recruitment,Regulatory Resource,Utilizing Patient Experience and Registry Data

Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data Developing and ...

FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making

Audience: Industry,Diversity & Engagement Modules,Guidance,Increasing diversity and inclusion in recruitment,Regulatory Resource

FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the ...

Select Language »

Disclaimer | Non-Discrimination | Privacy | Terms for Creating and Maintaining Sites